Variant report
Variant | nsv519656 |
---|---|
Chromosome Location | chr13:85052477-85061028 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9546709 | chr13:85052477-85052478 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs111511927 | chr13:85052518-85052519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143236561 | chr13:85052521-85052522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs183497618 | chr13:85052559-85052560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9546710 | chr13:85052568-85052569 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs543975199 | chr13:85052581-85052582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188548757 | chr13:85052586-85052587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375526078 | chr13:85052643-85052644 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561622532 | chr13:85052647-85052648 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs530565007 | chr13:85052672-85052673 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112488928 | chr13:85052743-85052744 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs570399743 | chr13:85052915-85052916 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532683639 | chr13:85052955-85052956 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs117529417 | chr13:85052976-85052977 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs117471139 | chr13:85053000-85053001 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs7983045 | chr13:85053039-85053040 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs117060318 | chr13:85053064-85053065 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547300437 | chr13:85053079-85053080 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74101168 | chr13:85053080-85053081 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs191996226 | chr13:85053090-85053091 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183338527 | chr13:85053126-85053127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35362045 | chr13:85053138-85053139 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs79659123 | chr13:85053141-85053142 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557090124 | chr13:85053204-85053205 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372590370 | chr13:85053218-85053219 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112854708 | chr13:85053235-85053236 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186975262 | chr13:85053240-85053241 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs111546350 | chr13:85053259-85053260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573117945 | chr13:85053281-85053282 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs7981966 | chr13:85053305-85053306 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs75489442 | chr13:85053314-85053315 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7982620 | chr13:85053336-85053337 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs544261457 | chr13:85053341-85053342 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs191343722 | chr13:85053344-85053345 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs569357522 | chr13:85053357-85053358 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532720654 | chr13:85053361-85053362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs552491261 | chr13:85053393-85053394 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566016634 | chr13:85053420-85053421 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184301205 | chr13:85053423-85053424 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144126714 | chr13:85053434-85053435 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs552582408 | chr13:85053444-85053445 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142142739 | chr13:85053448-85053449 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs60660970 | chr13:85053449-85053450 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs376130430 | chr13:85053450-85053451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554108774 | chr13:85053451-85053452 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11842048 | chr13:85053453-85053454 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs145508464 | chr13:85053459-85053460 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139065707 | chr13:85053463-85053464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs68154061 | chr13:85053474-85053475 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142464157 | chr13:85053478-85053479 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Epilepsy | 20502679 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:85045200-85055200 | Weak transcription | Aorta | Aorta |
2 | chr13:85052600-85053800 | Enhancers | Osteobl | bone |
3 | chr13:85052600-85054200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr13:85052800-85053000 | Enhancers | Placenta Amnion | Placenta Amnion |
5 | chr13:85052800-85053800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr13:85053000-85054000 | Weak transcription | Placenta Amnion | Placenta Amnion |
7 | chr13:85053200-85054600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr13:85053200-85054600 | Enhancers | HMEC | breast |
9 | chr13:85053200-85054600 | Enhancers | NHEK | skin |
10 | chr13:85053400-85054000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr13:85053600-85054400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr13:85053800-85054800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
13 | chr13:85054000-85054600 | Enhancers | Placenta Amnion | Placenta Amnion |
14 | chr13:85054000-85056000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
15 | chr13:85054200-85055800 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr13:85054800-85055400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr13:85055400-85055800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
18 | chr13:85055600-85056600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr13:85055800-85056400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
20 | chr13:85055800-85056600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
21 | chr13:85056000-85056600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
22 | chr13:85056200-85056400 | Enhancers | HMEC | breast |
23 | chr13:85056200-85056400 | Enhancers | NHEK | skin |